Activatable Zymography Probes Enable In Situ Localization of Protease Dysregulation in Cancer.
Ontology highlight
ABSTRACT: Recent years have seen the emergence of conditionally activated diagnostics and therapeutics that leverage protease-cleavable peptide linkers to enhance their specificity for cancer. However, due to a lack of methods to measure and localize protease activity directly within the tissue microenvironment, the design of protease-activated agents has been necessarily empirical, yielding suboptimal results when translated to patients. To address the need for spatially resolved protease activity profiling in cancer, we developed a new class of in situ probes that can be applied to fresh-frozen tissue sections in a manner analogous to immunofluorescence staining. These activatable zymography probes (AZP) detected dysregulated protease activity in human prostate cancer biopsy samples, enabli
SUBMITTER: Soleimany AP
PROVIDER: S-EPMC8244999 | biostudies-literature | 2021 Jan
REPOSITORIES: biostudies-literature
ACCESS DATA